AI, Pharma, and the Future of Patient Care | Jason Burke
BioTalk Unzipped15 Mai 2024

AI, Pharma, and the Future of Patient Care | Jason Burke

What happens when AI begins designing drugs, healthcare data becomes a strategic asset, and software starts changing faster than companies can adapt?

Jason Burke returns to BioTalk Unzipped to explore the intersection of artificial intelligence, biotechnology, healthcare, entrepreneurship, and technology strategy.

Jason explains the distinctive approach of the Duke program and the value of exposing students to real-world healthcare datasets rather than purely academic exercises.

The conversation then turns to AI-generated drug discovery and what these technologies could mean for pharmaceutical companies, biotechnology startups, investors, and patients.

Jason also explains how he assesses emerging technologies by looking beyond technical capability to questions of business value, intellectual property, scalability, and practical adoption.

Gregory, Chad, and Jason then tackle a deeper structural problem: pharmaceutical companies develop products for healthcare systems, yet the two sectors do not always interact as closely as they should. They examine the complexity facing physicians and ask whether life-sciences companies may increasingly need to think not merely as product developers, but as providers of services and solutions.

Finally, the science gets wonderfully unconventional as Jason takes us into amateur radio, including bouncing radio signals off the Moon.

Chapters

00:29 - The unique approach of the Duke program

05:14 - New News: AI-generated drug discovery

09:33 - Assessing technologies for companies and patients

11:52 - Why unique intellectual property matters

12:35 - The future of AI and software

13:36 - Data as a commodity

15:10 - Innovation curves, technology, and how AI may compress them

16:41 - Using AI in everyday life

19:04 - Why were search-engine companies late to the generative-AI game?

20:05 - New forms of software and digital experiences

22:53 - The future relationship between healthcare and pharma

25:08 - The difficulty of practicing medicine in complex environments and implementing precision medicine

29:03 - Jason’s interest in amateur radio and the ham-radio community

31:39 - Bouncing a radio signal off the Moon and sending email over radio waves

Connect with Jason Burke

Jason Burke

https://www.linkedin.com/in/jasonburke/

Creo Inc.

https://www.creoinc.net/

Connect with the hosts

Dr. Chad Briscoe

https://www.linkedin.com/in/chadbriscoe/

Gregory Austin

https://www.linkedin.com/in/gregoryaustin1/

#AI #pharmaceutical #healthcare #drugdiscovery #futuretech #lifesciences

Denne episoden er hentet fra en åpen RSS-feed og er ikke publisert av Podme. Den kan derfor inneholde annonser.

Episoder(45)

Why Gene Therapy Is Still So Hard to Manufacture at Scale | Phillip Ramsey

Why Gene Therapy Is Still So Hard to Manufacture at Scale | Phillip Ramsey

Why is gene therapy still so difficult to manufacture at scale after decades of progress?Phillip Ramsey, Chief Technical Officer at Sangamo Therapeutics, joins BioTalk Unzipped for a candid conversati...

8 Aug 11min

Her Daughter’s Brain Tumor Turned Her Into a Biotech Founder | Tracy Ryan

Her Daughter’s Brain Tumor Turned Her Into a Biotech Founder | Tracy Ryan

A mother’s search for answers to her daughter’s relentless brain tumor led her into natural killer cell biology, cancer immunotherapy, and biotech entrepreneurship.Sponsored by Leucentra, https://leuc...

20 Jul 1h 4min

The Future of Oncology Drug Development | Dr. Lakshmi Amaravadi

The Future of Oncology Drug Development | Dr. Lakshmi Amaravadi

Oncology drug development is becoming more complex, and bioanalysis can no longer be treated as simple drug measurement.Sponsored by Leucentra, https://leucentra.com/Inspired by science, empowered by ...

11 Jun 29min

Active Machine Learning for Drug Discovery & Nanomedicine with Dr. Daniel Reker

Active Machine Learning for Drug Discovery & Nanomedicine with Dr. Daniel Reker

Can artificial intelligence help make cancer therapies safer, more targeted, and more effective?In this episode of BioTalk Unzipped, Gregory Austin sits down with Dr. Daniel Reker, Assistant Professor...

25 Apr 50min

Why Haven’t We Cured Cancer Yet? | Dr. Bob Liu Explains

Why Haven’t We Cured Cancer Yet? | Dr. Bob Liu Explains

Why haven’t we cured cancer yet? A Genentech scientist explains the real reason.In this episode of BioTalk Unzipped, Gregory Austin and Dr. Chad Briscoe sit down with Dr. Bob Liu, Senior Principal Sci...

19 Mar 1h

The Intersection of Biotech, Patent Law, and AI with Dr. Kate Neville, IP Attorney

The Intersection of Biotech, Patent Law, and AI with Dr. Kate Neville, IP Attorney

Recorded October 31, 2025In this episode of BioTalk Unzipped, Gregory Austin and Dr. Chad Briscoe sit down with Dr. Kate Neville, immunologist turned seasoned biotech patent attorney at Marshall, Gers...

16 Feb 52min

Long-acting Cell-Based Gene Therapy, Fabry Disease and Beyond with Glafabra CEO, Dr. Chris Hopkins

Long-acting Cell-Based Gene Therapy, Fabry Disease and Beyond with Glafabra CEO, Dr. Chris Hopkins

In this episode of BioTalk Unzipped, hosts Gregory Austin and Dr. Chad Briscoe sit down with Glafabra CEO: Dr. Chris Hopkins, geneticist, biochemist, and biotech entrepreneur, to explore the science a...

22 Des 202549min

Fail Fast, Learn Faster: Drug Development in Rare Disease with Dr. Binodh DeSilva

Fail Fast, Learn Faster: Drug Development in Rare Disease with Dr. Binodh DeSilva

In this episode of BioTalk Unzipped, Gregory Austin and Dr. Chad Briscoe sit down with Dr. Binodh DeSilva, Senior Vice President of Bioanalysis at Ultragenyx Pharmaceutical, to explore the science and...

23 Okt 202531min

Populært innen Business og økonomi

stopp-verden
lydartikler-fra-aftenposten
dine-penger-pengeradet
rss-penger-polser-og-politikk
e24-podden
rss-borsmorgen-okonominyhetene
rss-skravla-gar
lederpodden
rss-pa-konto
utbytte
pengepodden-2
livet-pa-veien-med-jan-erik-larssen
morgenkaffen-med-finansavisen
finansredaksjonen
tid-er-penger-en-podcast-med-peter-warren
liberal-halvtime
rss-markedspuls-2
pengesnakk
rss-politisk-preik
okonomiamatorene